|
| 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone Basic information |
Product Name: | 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone | Synonyms: | 5,7-Dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one;5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone;5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxychromen-4-one;Rrigenin;4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-;5,7-Dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4H-chromen-4-one;inhibit,cancer,lung,transition,metastasis,Irigenin,Integrin,apoptosis,Epithelial-Mesenchymal,C-C,TRAIL,EDA,gastric,loop,carcinoma,Inhibitor | CAS: | 548-76-5 | MF: | C18H16O8 | MW: | 360.31 | EINECS: | 208-958-3 | Product Categories: | | Mol File: | 548-76-5.mol | |
| 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone Chemical Properties |
Melting point | 189-192℃ | Boiling point | 646.1±55.0 °C(Predicted) | density | 1.461±0.06 g/cm3 (20 ºC 760 Torr) | storage temp. | 2-8°C | solubility | Soluble in ethanol and methan | pka | 6.36±0.20(Predicted) | form | powder | color | White |
| 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone Usage And Synthesis |
Uses | Irigenin is identified as an α-glucosidase inhibitors. Also, it is a lead compound to overcome Fibronectin EDA induced metastatic progression in lung carcinoma cells. | Definition | ChEBI: A hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3' and methoxy groups at positions 6, 4' and 5' respectively. | target | COX | NOS | NAD(P)H:quinone reductase | α-glucosidase | NO | PGE | p65 | NF-κB |
| 5,7-dihydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4-benzopyrone Preparation Products And Raw materials |
|